Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History
Ahmad Masri, Hongya Chen, Catherine Wong, Katherine Fischer, Chafic Karam, Walid F. Gellad, Stephen B. Heitner
Abstract
This economic evaluation study examines the authors’ experience of prescribing tafamidis in terms of their cost and the insurance status of patients.
Topics & Concepts
MedicineMEDLINEIntensive care medicinePolitical scienceLawAmyloidosis: Diagnosis, Treatment, OutcomesCoagulation, Bradykinin, Polyphosphates, and AngioedemaEosinophilic Disorders and Syndromes